INTRODUCTION
============

Methylation of cytosine bases is a commonly occurring modification of deoxycytidine monophosphate (dCMP) pre-replicatively and of deoxycytidine (dC) in DNA post-replicatively ([@B1; @B2; @B3; @B4; @B5]). Post-replicative methylation of dC in prokaryotic genomes, either of carbon 5 (m^5^C) or of the exocyclic N4 atom (m^N4^C), is mediated by site-specific DNA methyltransferases (DNMTs). These modifications protect against degradation by cognate restriction endonucleases ([@B6]).

Many organisms regulate diverse genomic processes through C-5 methylation of CG (CpG) sites (i.e. m^5^CG) by endogenous DNMTs. These processes include inactivation of: gene expression at the level of transcription initiation or elongation, one of two X chromosomes in normal female mammals, either the maternal or paternal copy of a gene (genomic imprinting) and mobility of parasitic genetic elements, e.g. retrotransposons ([@B1],[@B2],[@B7]). Aberrant patterns of DNA methylation are frequently associated with human disorders, aging, carcinogenesis and developmental defects ([@B2],[@B8; @B9; @B10; @B11; @B12]). In addition to CG methylation, land plants, such as *Arabidopsis*, employ non-CG methylation of transposable elements ([@B1],[@B13; @B14; @B15; @B16; @B17]). Short transposable elements are particularly enriched for m^5^CHH, where H is a degenerate base equal to A, C or T. Ascomycetes, such as the filamentous fungi *Ascobolus immersus* and *Neurospora crassa*, 5-methylate dC within repeats in a relatively sequence-independent manner ([@B17],[@B18]). Abundant non-CG methylation (m^5^CHG and m^5^CHH) has also been reported in undifferentiated human embryonic stem cells ([@B19; @B20; @B21; @B22; @B23; @B24]). Non-CG methylation is also found in the genomes of lytic *Chlorella* viruses that infect and degrade the genome of fresh water *Chlorella*-like green algae ([@B25; @B26; @B27; @B28]). In this case, progeny viral genomes are protected post-replicatively against degradation by site-specific introduction of m^5^C by DNMTs, e.g. M.CviPI (G-m^5^C) and M.CviPII (m^5^CCD, m^5^Cm^5^CAA and m^5^Cm^5^CCG), that they encode ([@B25; @B26; @B27; @B28]).

Bisulfite genomic sequencing (BGS) is a widely used technique for assaying cytosine methylation status in DNA ([@B29],[@B30]). Bisulfite ion can quantitatively convert unmethylated C in denatured DNA to U, whereas m^5^C, m^N4^C and hm^5^C resist chemical deamination and thus are retained ([@B31; @B32; @B33]). BGS can be used to display these three and perhaps other types of cytosine modification as they are discovered ([@B34]). Individual molecules from a PCR product population can be cloned and sequenced, mapping the methylation status of every cytosine along a single DNA strand at nucleotide resolution ([@B29],[@B30]).

DNMTs are also effective probes, either as purified enzymes or as transgenes expressed *in vivo*, for mapping protein--DNA interactions ([@B35; @B36; @B37; @B38; @B39; @B40; @B41]). DNMTs methylate target sites that are unoccupied by proteins and hence are easily accessed ([@B35; @B36; @B37; @B38],[@B42]). Conversely, occupancy of DNMT target sites by histones or non-histone proteins protects against methylation and produces a 'footprint' at the site of factor interaction ([@B37],[@B42; @B43; @B44; @B45]). Availability of DNMTs that recognize and methylate cytosines in specific dinucleotide sites, e.g. M.CviPI (GC) and M.SssI (CG) ([@B28],[@B46],[@B47]), allows moderate- to high-resolution footprinting, depending on local site density. Additional enzymes with novel short recognition specificities would increase probing resolution and hence obtainable mapping information.

Combining DNMT probing with BGS provides a powerful non-averaged, single-molecule view of chromatin structure, termed methyltransferase accessibility protocol for individual templates (MAPit) ([@B39; @B40; @B41],[@B48; @B49; @B50]). Because a continuous strand of DNA is cloned, i.e. regions are not fragmented by nuclease digestion, multiple methylation events and hence footprints can be detected along a single DNA strand ([@B39; @B40; @B41],[@B48; @B49; @B50]). Manual assignment of the methylation status of every C of many sequenced molecules is time consuming, labor intensive and subject to human error. Manual analysis of raw BGS results is therefore impractical for large-scale projects.

Attempts to alleviate these problems have led to development of several software programs that deal with individual steps in the BGS process: (i) primer design ([@B51; @B52; @B53]); (ii) alignment of sequenced bisulfite-converted molecules ([@B54; @B55; @B56]); and (iii) generation of graphical or text-based outputs ([@B53],[@B54],[@B56; @B57; @B58; @B59]). Some of these programs require computer literacy beyond that of the typical biomedical researcher. In addition, only one program, CpGviewer ([@B60]), which we developed previously, offers a stand-alone solution to the BGS pipeline. However, CpGviewer and each of the above programs is limited to methylation analysis of CG, or additional sites in plants, CHG, CHH and CNG, where N is any nucleotide and H is either A, C or T. Furthermore, currently available programs are unable to simultaneously analyze and diagram methylation by multiple enzymes, which may vary from one experiment to another, as is often required for MAPit footprinting studies.

We have developed a BGS analysis program, called MethylViewer, which circumvents these and other limitations. MethylViewer was written to facilitate analysis of MAPit experiments, and is a substantially improved and more versatile version of CpGviewer ([@B60]). A key feature of MethylViewer is that it can simultaneously analyze and distinguish between cytosine methylation in bisulfite-converted sequences at as many as four different, user-defined sequence motifs, including C by itself. The program also has a utility for designing primers for MAPit, directly aligns most common sequencing file formats or processes pre-aligned FASTA files, and generates publication-quality images. Here, the usefulness of MethylViewer is demonstrated by analyzing \*.ab1 sequencing files from MAPit analysis of the h*MLH1* tumor suppressor gene promoter from colorectal cancer cell lines. Our use as chromatin probe of M.CviPI, which we previously cloned and found methylates GC ([@B28]), permitted simultaneous detection of endogenous CG methylation and chromatin accessibility within single mammalian sequences. As such, our data provide the first single-molecule view of chromatin accessibility at an endogenously hypermethylated CpG island. Also, at a well-characterized yeast promoter, we showcase for the first time use of M.CviPII, a CCD DNMT, as an *in vivo* chromatin probe. We conclude that MethylViewer is a powerful computational resource for accurate and rapid BGS analysis of complex DNA methylation data sets, including those with methylation at degenerate or multiple sites of any sequence of interest.

MATERIALS AND METHODS
=====================

Software development and requirements
-------------------------------------

Microsoft Visual Studio 2005 was used for programming using the Visual Basic language. The MethylViewer program has been tested only on Microsoft Windows XP, Vista and Windows 7, and requires installation of .NET framework 2.0. The stand-alone graphical user interface program and accompanying documentation are freely available for download at <http://dna.leeds.ac.uk/methylviewer/>.

Cell lines, yeast plasmids and strains, growth media and cell culturing
-----------------------------------------------------------------------

HCT116 and RKO colorectal cancer cell lines were obtained from the American Type Tissue Culture Collection. Cells were cultured in minimal Eagle's medium (MEM) supplemented with 10% (v/v) fetal bovine serum and 1% (w/v) penicillin and streptomycin, following the provider's recommendations.

The full-length coding region for M.CviPII ([@B27]) was subcloned under control of estrogen induction into a single-copy integration vector as described earlier in Jessen *et al.* ([@B38]). The resulting *LYS2*-marked plasmid, pCF1439, was digested with R.AscI and R.SalI and integrated as a single copy at the *HO* locus in budding yeast strain, SCY3854 (*MAT***a** *leu2Δ0 lys2Δ0 ura3Δ0 pho3Δ*::*R PHO5*^HhaI^ promoter) ([@B39]). The *PHO5*^HhaI^ promoter contains several single nucleotides substitutions into the wild-type *PHO5* promoter that introduced several HhaI sites and was described previously ([@B39]). R in this strain is a single copy of the recombinase site for *Zygosaccharomyces rouxii* that is a remnant after removal of the marker used to delete the *PHO3* coding region ([@B61]). The constructed strains CFY4011 and CFY4012 were grown to mid-log phase in rich YPD medium \[1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) dextrose\] and grown 10 h more in the presence of 100 nM 17β-estradiol to induce M.CviPII expression.

Nuclei isolation and MAPit analysis
-----------------------------------

Nuclei from HCT116 and RKO cells were isolated from ∼4--7 × 10^6^ cells at 4°C under buffer conditions that preserve the integrity of nuclei and chromatin structure (40). After harvesting, cells were washed twice with phosphate-buffered saline (PBS) and resuspended in 1× cell resuspension buffer \[CRB; 20 mM HEPES, pH 7.5, 70 mM NaCl, 0.25 mM EDTA, 0.5 mM EGTA, 0.5% glycerol (v/v), 10 mM DTT, 0.25 mM phenylmethylsulfonyl fluoride\]. After pelleting by centrifugation at 1000 × *g*, cells were resuspended in cell lysis buffer (CLB; 1× CRB plus 0.19% NP-40) for 10 min on ice. Nuclei were then washed twice with CRB and a 2 µl aliquot was stained with 4% (w/v) trypan blue and visualized by light microscopy to confirm their integrity. One million nuclei were resuspended in methylation buffer (MB; 1× CRB plus 160 µM *S*-adenosylmethionine). After pre-warming nuclei to 37°C for 5 min, 100 U of M.CviPI (New England Biolabs) were added for 15 min at 37°C. Methylation reactions were stopped by adding an equal volume of 2× methylation stop buffer \[MSB; 100 mM NaCl, 10 mM EDTA, pH 8.0, 1% SDS (w/v)\], and then incubated overnight with 100 µg/ml proteinase K at 50°C. DNA was isolated by extraction with phenol:chloroform:isoamyl alcohol (25:24:1) and concentrated by ethanol precipitation.

m^5^C analysis
--------------

Bisulfite conversion of total genomic DNA from yeast and cultured mammalian cells was carried out as described in Darst *et al.* ([@B62]). Briefly, 1--2 µg DNA were denatured in alkali for 15 min at room temperature, followed by 5 min at 98°C. Saturated sodium metabisulfite solution, pH 5.0 was added directly to each denatured sample, vortexed and incubated in the dark for 4--6 h at 50°C. Bisulfite-converted DNA was desalted, desulfonated and purified with the EZ bisulfite DNA clean-up kit (Zymo Research).

Oligonucleotide primers were designed as described in Pardo *et al.* ([@B41]) to avoid as much as possible not only potential endogenous methylation sites (CG) but also M.CviPI (GC) sites. A 755-bp region encompassing the two transcription start sites (TSS) of h*MLH1* was analyzed for DNA methylation. Hot-start PCR was performed with HotStar Taq Plus (Qiagen). To minimize stochasticity due to PCR, at least three separate PCR reactions were performed for each amplicon and pooled prior to cloning individual products. Oligonucleotides CPO1842 (TaaATaTaAACAaATaATTTCTaaAATaAATa, with G to a transitions) and CPO1843 (GGAGGGAYGAAGAGAttt, with C to t transitions and one degenerate pYrimidine, i.e. C and T) were used for PCR amplification of the upper strand of h*MLH1* sequences from bisulfite-converted DNA.

For the yeast experiment, genomic DNA was prepared by the phenol/chloroform extraction method ([@B63]) and deaminated as in ([@B64]). DNA methylation was confirmed by McrBC digest ([@B65]). *PHO5* promoter sequences (500 bp) were amplified from bisulfite-converted DNA with primers WJO766 (ATATAT[CTCGAG]{.ul}AATATaTCAACaTATTTaaAAaTCATCTTATa; 5′ XhoI site underlined; lower case indicating G to a transitions) and WJO769 (ATATAT[AAGCTT]{.ul}CAAtATTGGTAATtTtGAATTTGtTTGtT; 5′ HindIII site underlined; lower case indicating C to t transitions).

After purification of PCR products with the QIAEX II gel extraction kit (Qiagen), individual DNA molecules were cloned by either TOPO TA cloning (Invitrogen; h*MLH1* sequences) or directionally into pBluescript−(Stratagene) digested with R.XhoI and R.HindIII (*PHO5* sequences). White *Escherichia coli* colonies that screened positive for potential recombinant plasmids were inoculated into 100 μl LB medium with 100 μg/ml kanamycin (TOPO TA cloning) or 100 μg/ml ampicillin (directional cloning), and incubated overnight at 37°C. Plasmid DNA was amplified directly from *E. coli* cells using TempliPhi rolling circle amplification (GE Healthcare). Cloned inserts in the resulting single-stranded DNA were subjected to BigDye sequencing and analyzed on an automated 3730 sequencer (Applied Biosystems) at the Interdisciplinary Center for Biotechnology Research at the University of Florida. The *PHO5* and h*MLH1* \*.ab1 files can be downloaded using: [http://dna.leeds.ac.uk/methylviewer/Example_Files_h*MLH1*.zip](http://dna.leeds.ac.uk/methylviewer/Example_Files_hMLH1.zip) and [http://dna.leeds.ac.uk/methylviewer/Example_Files\_*PHO5*.zip](http://dna.leeds.ac.uk/methylviewer/Example_Files_PHO5.zip), and are also available at NAR Online. Note that the wild-type reference sequences should be moved to location on the hard drive outside of the folder containing the \*.ab1 files prior to analysis.

Analysis of bisulfite-converted sequences
-----------------------------------------

The alignment algorithm in MethylViewer uses an array of overlapping DNA fragments created from the wild-type reference sequence that can be changed from the 10-bp default length to word sizes of 6--15 bp via **Analysis \> Alignment option \> Word size ... **. These words are then used to find regions of 100% homology between the reference sequence and the query sequence. Each region is extended until the ends of the alignment have \<80% identity. Local alignments are then concatemerized to create the longest possible global alignment with the minimum number of gaps. Since the sequence of bisulfite-treated DNA may be significantly different from the original sequence, alignments are created between both the original sequence and the theoretical bisulfite-treated reference sequence to ensure that an alignment is created. Similarly, the alignment is also performed against the forward and reverse complement of the native and bisulfite-treated reference sequence to identify the orientation of the cloned DNA.

The reference sequence is scanned for the presence of any methylation sites and this information is superimposed on the alignment to identify the methylation status of each site. This information is then collated for each of the experimental sequences and used to form the interactive grid displayed by MethylViewer as well as other exported images.

RESULTS
=======

MAPit for simultaneous detection of endogenous m^5^CG and chromatin accessibility in individual mammalian DNA strands
---------------------------------------------------------------------------------------------------------------------

Transcriptional inactivation of the human tumor suppressor gene h*MLH1* by hypermethylation of the CG island associated with its promoter is a frequent contributor to colon cancer progression ([@B66; @B67; @B68]). The h*MLH1* promoter is active in HCT116 cells where its CG island is hypomethylated ([@B8],[@B68; @B69; @B70; @B71]). By contrast, the h*MLH1* CG island is hypermethylated and the gene is transcriptionally silent in RKO cells. In a recent study, Lin *et al*. ([@B72]) reported that chromatin near the two transcription start sites (TSS), TSSa and TSSb, of active alleles of h*MLH1* in HCT116 cells was accessible to nucleases and M.SssI at individual promoters within isolated nuclei. Regions upstream of both TSS in this cell line were also shown to be depleted for nucleosomes as assayed by chromatin immunoprecipitation of the globular region of histone H3 in isolated mononucleosomes. However, single-molecule methylation footprinting of the hypermethylated h*MLH1* promoter in RKO cells using M.SssI was ambiguous because the probe has the same specificity for CG as vertebrate DNMTs.

We have overcome this drawback by using as chromatin probe M.CviPI, a DNMT from *Chlorella virus* NYs-1 that specifically methylates C in GC sites ([@B28]). Thus, sequencing cloned, bisulfite-converted molecules after probing mammalian chromatin with M.CviPI should allow clear discrimination between non-overlapping G-m^5^C and endogenous m^5^CG within accessible regions of mammalian chromatin. We performed MAPit by probing nuclei isolated from HCT116 and RKO cells that respectively express and silence the h*MLH1* promoter with 0 or 100 U of M.CviPI. The original \*.ab1 sequence files, FASTA alignments of four sequences from each sample, MethylViewer, and other files to familiarize users with the program's features are available for downloading on the companion website (<http://dna.leeds.ac.uk/methylviewer/download.php>). This site also contains detailed instructions for use of the program.

Analysis of mammalian MAPit data with MethylViewer
--------------------------------------------------

Users are first prompted to **Select a function from the menu above** when MethylViewer is executed ([Figure 1](#F1){ref-type="fig"}A). The program supports two different means for analysis of bisulfite-converted sequences ([Figure 1](#F1){ref-type="fig"}B). First, raw sequencing data in either \*.txt, \*.ab1, or \*.scf file format can be aligned without pre-processing by **Analysis \> Interactive view ... **. A \*.txt reference that is the wild-type sequence is required, avoiding the need to generate bisulfite-converted reference sequences *in silico*. Because MethylViewer can interpret methylation at non-palindromic sites, and DNA strands are no longer complementary after bisulfite conversion, the wild-type reference sequence must be that of the DNA strand that was sequenced. After navigating to and selecting the reference sequence file and the folder containing data files, the program generates the alignment via a local extension algorithm that is similar to BLAST ([@B73]). Figure 1.MethylViewer initial window. The initial window after loading MethylViewer.exe (**A**) and **Analysis \> Alignment options** (**B**). **Minimum alignment score ... **can be set with increased stringency from 15 to 50 upon activating the pop-up window. Likewise, users can set the **Base calling cut off ... **for the signal threshold (15 to 300) for calling bases in sequencing traces and **Word size** ... of the base pair length of the array of overlapping DNA fragments (6 to 15) created from the wild-type reference sequence for use in the BLAST-like local extension algorithm. Clicking the mouse on **Interactive view ... **or **Import FASTA alignment ... **activates the **Methylation sites** window shown in [Figure 3](#F3){ref-type="fig"}A. Figure 2.FASTA file format. The wild-type sequence and proper strand of the region of interest must appear as the first entry. Names of individual aligned sequences can include any number of alpha-numeric characters; however, the program will reduce the font size of labels in exported images to fit within the allotted space. Users must be certain to erase all non-alpha-numeric characters from the file, except \> and \<.

**Analysis \> Import FASTA alignment** provides a second analysis option ([Figure 1](#F1){ref-type="fig"}B). After clicking on this option, users navigate to a FASTA file in the format shown in Figure 2 that contains sequences pre-aligned by another program. The first entry in this \*.txt file must be the wild-type reference sequence of the DNA strand being analyzed to which the bisulfite-converted sequences are aligned.

Choosing either option in the **Analysis** menu launches a floating window for designating the sequences of sites at which methylation is to be scored ([Figure 3](#F3){ref-type="fig"}A). Preset selection buttons for **CG** only, **GC** only and **CG and GC** are provided. Presets for CG only or GC only employ as defaults the usual convention of depicting unmethylated CG or GC as white-filled circles and methylated sites (m^5^CG or G-m^5^C) as black-filled circles, organized in horizontal rows. Figure 3.Default settings for MAPit methylation footprinting analysis. (**A**) **Methylation sites** window activated by clicking on **Analysis \> Interactive view ... **or **Import FASTA alignment ... **. If the default setting of CG and GC (see keys in [Figures 4](#F4){ref-type="fig"}A and [10](#F10){ref-type="fig"}D) is acceptable, the user then selects the indicated files as prompted in the window. (**B**) **Custom methylation sites** window activated by clicking the **Custom** button in A. Shown are the default settings for CG methylation analysis: methylated dC residues at position 1 indicated in black. Note that the **Include the site** field indicates CG: 1. Toggling to GC: 2 shows the second setting, methylation of dC residues at position 2 in GC sites to be indicated in red. The circle and triangle symbols are gray because they are set as defaults for indicating methylation status of CG and GC sites, respectively, in exported images (e.g. [Figure 10](#F10){ref-type="fig"}).

The default setting, CG and GC, facilitates analysis of MAPit data for vertebrate samples that require analysis of methylation status at endogenous CG sites as well as at GC sites probed by M.CviPI exogenously added to nuclei.

The default symbols and colors can be visualized and changed by clicking the **Custom** preset button ([Figure 3](#F3){ref-type="fig"}A), which launches the **Custom methylation sites** floating window ([Figure 3](#F3){ref-type="fig"}B). As usual, CG and m^5^CG are depicted as white- and black-filled circles, respectively. White- and red-filled inverted triangles are the depictions for GC and G-m^5^C sites, respectively. Selecting **GC: 2** in the toggle window under **Include the site** displays the default settings of methylation of residue 2 and red color (not shown). The options buttons for circle and inverted triangle symbols in the **Select symbol** bar at the bottom of the window are gray and unavailable as they have already been designated for scoring CG and GC sites. Overlapping methylation, e.g. at GC and CG sites (G-m^5^CG), is indicated as gray-filled cells in each grid. This is because they constitute 'gray areas' that in principle could have been methylated by either endogenous DNMTs or M.CviPI chromatin probe. This default convention cannot be changed and thus does not appear in the Custom methylation sites window.

Viewing mammalian MAPit data by MethylViewer
--------------------------------------------

User-defined symbols and colors are drawn in **Export data \> Save image drawn to scale** as discussed further below. Initially, however, MethylViewer processes and shows the methylation status for every C in sites aligned to the reference sequence as an interactive grid composed of color-coded cells as chosen by the user. [Figure 4](#F4){ref-type="fig"} shows representative BGS grids generated from \*.ab1 files of four bisulfite-converted h*MLH1* promoter molecules that were amplified, cloned and sequenced from HCT116 and RKO nuclei incubated with either 0 or 100 U M.CviPI. The default CG and GC setting was used for analysis of the 0 U M.CviPI samples so that the number of scored sites and hence grid sizes would be identical to aid comparisons of different samples. MethylViewer can be executed multiple times to generate as many grids as needed. Figure 4.MethylViewer interactive data grids. (**A**) Data key. (**B--E**) Interactive grids showing raw, unedited methylation data processed from \*.ab1 files via **Analysis \> Interactive view ... \> CG and GC** for HCT116 nuclei treated with 0 U M.CviPI (B), HCT116 nuclei + 100 U M.CviPI (C), RKO nuclei + 0 U M.CviPI (D) and RKO nuclei + 100 U M.CviPI (E). The shown grids were generated with the default **Base calling cutoff** of 20 and maximum alignment **Word size** of 15. Each column, except for column 1, contains data for a specific potential methylation site in the reference sequence. Each row, except for the header row 1, represents the unedited sequencing calls (C or T) for each of four cloned and sequenced molecules. Placing the cursor over any cell in the grid, except for those in the header column 1, displays the corresponding sequence of the scored site in a small pop-up window as shown in B, D and E. An alternate way to view sites is to select **View \> Identify methylation sites**, which displays the colors of each methylated dC site as shown in C. In addition, clicking on a light blue or color-coded header cell in row 1, except the first cell, displays specific information about a site as shown in D. Lastly, left-clicking on any cell in the grid displays the file number and sequence of that scored site (C or T) as seen in E. Pop-up windows and sub-menus only obscure white cells with unmethylated residues.

Rows 2--5 of each grid correspond to residues in DNMT sites in each of the four bisulfite-converted sequences from the indicated cancer cell line ± M.CviPI. The key in [Figure 4](#F4){ref-type="fig"}A is for grids generated with the default MAPit settings shown in [Figure 3](#F3){ref-type="fig"}B. A key with colors assigned to each methylated site can also be displayed in row 1 of grids by selecting **View \> Identify methylation sites** ([Figure 4](#F4){ref-type="fig"}C). The size of grid cells can be increased via **View \> Cell width of interface \> Large** to better visualize assigned colors, especially if more DNMT sites are analyzed. Placing the cursor over any cell in a grid, except for header blue cells in column 1, also displays corresponding site sequence(s) in a small pop-up window ([Figure 4](#F4){ref-type="fig"}B, D and E). If sequencing data files have been analyzed, left-clicking on these header cells (left- or right-clicking for analysis of FASTA files) indicates the site number and position relative to base pair 1 in the wild-type reference sequence ([Figure 4](#F4){ref-type="fig"}D). Cells representing residues in DNMT sites that sequenced as T are colored white. Cells for non-overlapping methylation that sequenced as C are colored according to the program's default settings ([Figure 4](#F4){ref-type="fig"}A), or as otherwise designated in Custom methylation sites. With a view toward analysis of large data sets, **Analysis \> Reanalyse alignment** allows analysis of methylation at additional sites while the window is open ([Figure 1](#F1){ref-type="fig"}B).

Data editing
------------

MethylViewer has been written to facilitate accurate analysis of BGS data; a central feature therefore is user-friendly editing of sequences within the interactive grid interface. These capabilities include viewing the quality of both sequencing data and local alignment of sites and flanking sequences, and re-assigning methylation status, if warranted. Cells representing sites in the grid at which local sequencing data could not be aligned to the reference sequence are colored orange ([Figure 5](#F5){ref-type="fig"}A), and cannot be edited. In contrast, residues within sites of molecules that were aligned to the reference sequence but unable to be assigned as C (unmethylated) or T (methylated) appear as yellow cells ([Figures 4](#F4){ref-type="fig"}B and C and [5](#F5){ref-type="fig"}A and B). This can be due to poor quality sequencing data, the presence of single nucleotide polymorphisms, or mutations that occurred during PCR amplification or cloning. Right-clicking on header blue cells in column 1 for any molecule offers the option in a pop-up window to view the entire ABI trace (not shown) of the sequencing data and examine its quality ([Figure 5](#F5){ref-type="fig"}A). Figure 5.Data editing. (**A**) Right-clicking on the light blue header cell offers the option to view the entire sequencing trace of a molecule. (**B**) Right-clicking on any non-header cell in the grid displays (**C**) the local alignment between the reference and query sequences as well as the sequencing trace encompassing the query site. The methylatable residue in both the reference and query sequences is indicated in red type in properly aligned sequences. In this example, the A residue in the upper query sequence (manually highlighted by red circle; reverse strand sequenced) is in black type, because it should have been aligned to the G in the reference sequence. That is, the gap in the alignment (indicated in A and B as a blue tracer line within the corresponding cell) should be placed at one of the three immediately downstream C residues. Therefore, clicking anywhere in the white field of this local alignment window displays a pop-up window to correct assignment of the nucleotide sequence; specifically, **G'T'**, because the corresponding nucleotide in the query molecule sequenced as 'A' (when aligned correctly). The base calling cutoff of 20 is indicated by the red horizontal line at the base of the peaks. (**D**) The corrected **G'T'** appears as a large white square within the original yellow cell for that nucleotide. Cells for which sequencing data was inspected and verified, and hence had unchanged sequencing calls, are marked by small green squares. The window scroll bar has been moved all the way to the right in this panel. (**E**) Right-clicking on the CG cell marked by the cursor in D showed deletion of an A in the query molecule. As this A or any other in the downstream run of adenines could have been deleted, the nucleotide assignment of the residue was changed to **Not aligned**. If FASTA files are used as input, right clicking on any non-header cell in the grid will display the entire text alignment between the reference and query sequence, with the inspected nucleotide marked by an asterisk.

Left-clicking on any non-header (non-blue) cell in the grid indicates the sequence of a residue, the name of the sequenced file and the site number relative to site 1, the first one aligned ([Figure 5](#F5){ref-type="fig"}B). Nucleotide numbers relative to site 1 associated with yellow grid cells are left blank because their sequence could not be unequivocally determined by MethylViewer. As all residues in DNMT sites should be C or T, residues that sequenced as G or A are also colored yellow (not shown).

In grids of \*.ab1 sequencing files, right-clicking on any non-blue cell allows inspection of both the ABI data trace and alignment between the reference and query sequence around that DNMT site ([Figure 5](#F5){ref-type="fig"}C). This allows users to verify sequencing calls made by MethylViewer as well as to determine if the quality of sequencing data associated with yellow cells merits assigning a specific nucleotide to it. In each sequencing trace, the residue indicated in red corresponds to that clicked on and thus being queried for methylation status ([Figure 5](#F5){ref-type="fig"}C). In this example and throughout, the G rather than C in GC site 49 was queried because the reverse strand was sequenced. It is clear in the fourth analyzed clone that one of the three cytosines inclusive of the C in GC site 49 was deleted (indicated by a blue trace over cells 49 and 50 in row 5 corresponding to sequenced clone 4 of [Figure 5](#F5){ref-type="fig"}B). Therefore, correct alignment between the red G in the reference and A in the query sequence supports assignment of site 49 as T or unmethylated. Clicking anywhere within the white area of the sequencing trace launches another pop-up window with several editing options ([Figure 5](#F5){ref-type="fig"}C). Selection of **G'T'** re-assigns the cell to its proper call of T. Such edited squares are identified by a square in the upper left corner of the original cell in the color scheme originally chosen for the grid ([Figure 5](#F5){ref-type="fig"}D). This square is intermediate in size between the tracking green square and the data cell. If no change to an interrogated cell is warranted, simply closing the ABI trace or selecting **Viewed** from the pop-up window marks the cell with a small tracking green square in its upper left corner ([Figure 5](#F5){ref-type="fig"}D).

MethylViewer also marked CG site 72 in two molecules with blue traces, because they had deletions of one (row 2) or two (row 5) G residues immediately downstream of the query G ([Figure 5](#F5){ref-type="fig"}D and E). The nucleotide in CG site 72 in row 2 was aligned to the reference and called as T (A in the sequenced reverse strand). However, it is formally possible that this residue was methylated and deleted instead of the downstream G, and thus we elected to change its assignment to **Not aligned** ([Figure 5](#F5){ref-type="fig"}E).

In grids created from pre-aligned FASTA files, a text alignment of the entire sequence of the reference and query molecule appears on right-clicking non-blue cells. The specific residue represented in the right-clicked cell is demarcated by an asterisk that can be located by scrolling through the alignment.

**Edit \> Save edited data to file ...** stores all changed nucleotides and green tracking squares in \*.edi files. Re-opening these files in MethylViewer via **Edit \> Open edit data file ... **allows return to data editing at one's convenience.

Viewing bisulfite conversion efficiency and location of non-converted cytidines
-------------------------------------------------------------------------------

In BGS, most residues that sequence as C do so because they are methylated and unconverted by bisulfite ion. Less frequently, C residues can also arise from failure to deaminate during the bisulfite conversion procedure. It is also possible that reversion of U or T to C occurs during PCR amplification of bisulfite-converted cytosines or during cloning. **View \> Show dC conversion map** displays all C residues to scale, i.e. appropriately separated according to base pair coordinates. C nucleotides not converted by bisulfite deamination (or mutations during PCR or cloning), excluding those within methylated DNMT target sites, are depicted as vertical blue tick marks ([Figure 6](#F6){ref-type="fig"}A). Placing the cursor over any residue in the dC conversion map indicates its base pair coordinate relative to base pair 1 of the reference sequence in a pop-up window. Residues scored in DNMT sites that sequenced as T are depicted as gray vertical ticks, whereas those that sequenced as C are shown as black ticks. The level of m^5^CG in the four HCT116 molecules is at background as only 1 of 168 scored CG sites sequenced as C, whereas there were two non-converted C nucleotides outside of DNMT sites (compare [Figure 6](#F6){ref-type="fig"}A to [Figure 5](#F5){ref-type="fig"}A and B). Clicking on any residue in this view displays both the ABI data trace and alignment between the reference and query sequence encompassing the DNMT site ([Figure 6](#F6){ref-type="fig"}B). As an alternative, **View \> Always show text alignment** can be selected to produce a full-length text alignment of the reference and query sequences in a scrollable window, with an asterisk marking the clicked on residue (not shown). This is the only option for inspecting alignments of sites in grids derived from FASTA files. As above, the G indicated in red is queried, because it is complementary to the C in the reverse strand that was sequenced. Figure 6.Bisulfite conversion status of dC sites not in queried methylation sites. (**A**) Visualization by **View \> Show dC conversion map**. Placing the cursor over any nucleotide position in the map displays its exact position in base pairs relative to base pair 1 in the reference in a pop-up window. Residues that sequenced as C (G on reverse strand) and lie outside of queried methylation sites are marked by a vertical blue line. Black and gray vertical lines indicate residues within target methylation sites that are methylated and unmethylated, respectively. (**B**) Clicking on any nucleotide as shown in A displays the local sequencing trace and alignment to which it is linked.

Single-molecule view of endogenous m^5^CG and chromatin accessibility by MAPit
------------------------------------------------------------------------------

Cursory visual inspection of the four edited sample data sets reveals that the h*MLH1* fragment contains a m^5^CG level at the background of bisulfite-conversion in HCT116 cells and dense m^5^CG in RKO cells ([Figure 7](#F7){ref-type="fig"}, compare black cells in A to C and B to D). In contrast to endogenous DNMTs, M.CviPI clearly accessed and methylated more sites at the h*MLH1* promoter in HCT116 than in RKO colorectal cancer cells ([Figure 7](#F7){ref-type="fig"}, compare red cells in B to D). These results are consistent with previous findings of epigenetic silencing by hypermethylation of h*MLH1* in the latter cell line ([@B8],[@B68; @B69; @B70; @B71]). Figure 7.Edited interactive grids for mammalian MAPit data. Nuclei from cell line HCT116 + 0 U M.CviPI (**A**), HCT116 + 100 U M.CviPI (**B**), RKO + 0 U M.CviPI (**C**) and RKO + 100 U M.CviPI (**D**). The same \*.ab1 files used in Figures 4--6 were used. Summary information for unedited data for all molecules in a grid is displayed by clicking the light blue cell at the upper left as shown in A and C. Note that the numbers need to be adjusted to accommodate cells with manually-changed sequencing calls. Left-clicking on the light blue header cell for each row, except row 1, shows information associated with that specific molecule as shown in B.

A summary breakdown between unmethylated and methylated residues (unedited) for all molecules in a grid is obtained by clicking on the blue cell at the head of row 1 ([Figure 7](#F7){ref-type="fig"}A and C). This function sums the total number of sites scored and the absolute number of unmethylated and methylated sites, including overlapping sites. In the sample data, each cloned and sequenced 755-bp molecule of the h*MLH1* promoter encompasses 84 DNMT sites, including 30 non-overlapping CG, 42 non-overlapping GC and 12 overlapping GCG sites. Thus, each sample grid with four analyzed molecules contains a total of 336 cells or sites.

Further details about individual molecules are obtained by clicking on blue cells that head each row in the grid, excluding row 1 ([Figure 7](#F7){ref-type="fig"}B). This displays the name of the specific sequence file that was scored to obtain that row of data, the total number of sites for which methylation status was assigned, and breakdown of the total number and percentage of methylated non-overlapping sites for each queried DNMT site motif. The total number of residues expected to be converted from dC to dT (not present in selected methylation sites) as well as the number of unconverted dC residues is also tallied. This function is useful as the summary blue header in row 1 sums the total number of unmethylated (or methylated) residues in all queried DNMT sites, even of different sequence. The overall breakdown in methylation of each DNMT site can be summed from each of the individual values. However, this is cumbersome when many molecules have been analyzed.

Therefore, in practice, it is simpler to obtain data summaries by querying for methylation of one DNMT sequence motif at a time. Selecting CG in the Methylation sites window for samples not treated with M.CviPI reveals only 1 of 162 accurately scored CG sites sequenced as C at the h*MLH1* promoter in HCT116 cells ([Figure 7](#F7){ref-type="fig"}A). This excludes four sites not aligned with the reference plus the two sites that we judged could not be aligned unequivocally. In contrast to this background level of m^5^CG (\<1%), 150 of 165 of typed CG sites in RKO cells were methylated (91%) ([Figure 7](#F7){ref-type="fig"}C).

To separately determine the frequency of non-overlapping methylation at CG and GC sites in samples treated with M.CviPI, custom NCG and GCN sites, respectively, are scored. This is done by choosing **Analysis \> Interactive view ... \> Custom** or **Analysis \> Import FASTA alignment \> Custom**, which activates the floating window for changing default settings ([Figure 8](#F8){ref-type="fig"}). Default sites (CG and GC) are first removed by clicking **Delete** twice. Next, NCG (or GCN) is input under **Enter degenerate or non-degenerate methylation site sequence**. This automatically displays the four possible NCG (or GCN) sequences under **Select any sites that you do NOT want to screen for**, and the box for GCG is checked. A toggle window is used to **Select the methylated dC residue on the forward strand** that is being queried for methylation in each DNMT site. Users also **Select a color to identify this site** from a toggle window and **Select symbol** at the bottom of the panel to depict each type of site in an exported image (see below). Clicking **Add** inputs the site designation and then **OK** is clicked to load the custom settings and close the window. Figure 8.MethylViewer maps any input methylation specificity. The shown window was activated by **Analysis \> Interactive view ... \> Methylation sites \> Custom** to determine frequencies of non-overlapping methylation in the MAPit data of [Figure 7](#F7){ref-type="fig"}. The default CG: 1 and GC: 2 sites were deleted; the settings in each field were input as shown, and site NCG: 2 was entered by clicking **Add**. Checking the box for GCG eliminates the overlapping site from the analysis. As many as four sites of any sequence containing one or more deoxycytidines, including non-palindromic sites, can be designated.

Using these settings, MethylViewer generated a grid reporting methylation of 110 of 115 (96%) scored non-overlapping CG sites at the h*MLH1* promoter in RKO cells (grid not shown). This high level of m^5^CG is similar to the level in the minus M.CviPI sample from RKO cells (96 ≈ 91%). Moreover, the high level of m^5^C corresponded to methylation of only 13 of 168 (7.7%) of scored non-overlapping GC sites (GCN with GCG omitted) by M.CviPI, indicating that chromatin is highly inaccessible in epigenetically-silenced copies of h*MLH1*. In contrast, in HCT116 cells where h*MLH1* was essentially unmethylated at endogenous CG sites and actively transcribed, the summary cell in the grid for GCN with GCG omitted indicate a high degree of accessibility to M.CviPI, with 92 of 167 (55%) scored non-overlapping GC sites being methylated.

Data saving options and publication-quality images
--------------------------------------------------

After making and editing an alignment, users can choose from several options to customize information included in exported files via the **Image options** menu ([Figure 9](#F9){ref-type="fig"}A). These options include: edited data; image resolution; and bisulfite dC conversion frequencies \[(expected number of C residues to convert observed after conversion) / expected × 100\], which are indicated at the right of each diagrammed molecule in exported images. In addition, selecting **Include labels in image files** appends the name of the original sequence data file (or sequence name following the first \> symbol in FASTA files; [Figure 2](#F2){ref-type="fig"}) at the left of each diagrammed molecule and labels DNMT site numbers. Including labels activates the further option **Include base position with labels**, which places these labels below the DNMT site numbers, if selected. A final option is to **Select range of site shown in images** ([Figure 9](#F9){ref-type="fig"}B), which allows users to export a subset of the data within a grid to an image. For example, sites not aligned between the reference and query sequences, i.e. orange cells, can be omitted from the exported image. The exported image can retain its original sites numbers or the user can elect to **Renumber sites**. Figure 9.Image options and data export. (**A**) Various features for generating and labeling exported images are selected from the shown drop-down menu. In this image, the default image resolution has been reset from 100 to 600 dots per inch (dpi). (**B**) Window launched by **Image options \> Select range of sites shown in images**. Shown are the default settings, which can be changed, for example, to remove sites not aligned at the beginning or end of aligned sequences. (**C**) Export data options are in the shown drop-down menu.

Once the desired Image options have been selected, MethylViewer can save data in several formats suitable for publication or further manipulation, using the **Export data** menu ([Figure 9](#F9){ref-type="fig"}C). Grid images, a text file and scaled images with the user-selected symbols and colors can be exported as bitmap (\*.bmp), portable network graphics (\*.png) or scalable vector graphics (\*.svg) files. **Export data \> Save as text file** provides a detailed, tab-delimited output that summarizes the sequence assigned to each scored DNMT site to facilitate further data analysis. If sequencing files were used to generate the grid, the alignment can also be exported as a text FASTA file, with or without the reference sequence.

[Figure 10](#F10){ref-type="fig"} shows \*.svg images exported by MethylViewer via **Export data \> Save image drawn to scale** from each edited grid in [Figure 7](#F7){ref-type="fig"}. These images contain symbols representing the methylation status of each DNMT site (see key at bottom of [Figure 10](#F10){ref-type="fig"}D) spaced according to their relative position along the DNA sequence. In addition, overlapping GC and CG, i.e. GCG sites, are indicated by both default symbols, gray-filled circles and gray-filled inverted triangles. Unconverted cytosines at sites excluding designated DNMT motifs (i.e. CG and GC in this example) are indicated by horizontal blue tick marks that intersect each horizontal line representing an individual molecule at their exact position in the sequence. The detailed dC conversion analysis can also be saved to identify sequences and areas with low conversion efficiencies. Bitmap images with 100, 1000 or a user-defined resolution \[dots per inch (dpi)\] can also be exported as shown in [Figure 9](#F9){ref-type="fig"}A. Figure 10.Publication-quality, scaled images of h*MLH1* MAPit data. Edited data from each of the grids in [Figure 7](#F7){ref-type="fig"} were exported with **Image options** as shown in [Figure 9](#F9){ref-type="fig"}, via **Export data \> Save image drawn to scale**, and saved using the \*.svg option. Nuclei from cell line HCT116 + 0 U M.CviPI (**A**), HCT116 + 100 U M.CviPI (**B**), RKO + 0 U M.CviPI (**C**), and RKO + 100 U M.CviPI (**D**). The image is identical to that produced by MethylViewer, except that the amplicon map at the top and legend at the bottom were added in Adobe Illustrator and labels at left were edited slightly (increased font size as well as capitalization and italicization as appropriate and to taste). Also inserted were red rectangles and blue ovals, depicting spans of GC sites methylated by exogenously added M.CviPI chromatin probe (according to 2:2 convention, see text) and inferred positions of nucleosomes, respectively. Bent arrows, TSSa and TSSb; translational initiation codon, ATG. The blue bar is to scale and indicates the 147 bp length of DNA within a nucleosome core particle.

In MAPit analysis, sites in DNA are methylated and hence accessible to DNMT probe if they are unoccupied by non-histone proteins or are not incorporated into a nucleosome ([@B37; @B38; @B39]). Spans of accessibility to M.CviPI were manually added according to a 2:2 definition in which two consecutively methylated GC sites denote accessible regions ([@B48]) ([Figure 10](#F10){ref-type="fig"}). By this definition, continuity of these 'open' regions is only broken by ≥2 unmethylated GC sites. We imposed an additional caveat whereby spans of accessibility were broken if two consecutive G-m^5^C sites were separated by ≥30 bp. Based on experience, this is a reasonable footprint size for a non-histone protein that could be bound, but is thus undetectable due to low GC site frequency. G-m^5^CG is ignored in denoting these accessible regions because it cannot be determined if cytosines in these sequences were methylated by endogenous DNMTs or M.CviPI. Nevertheless, given the near absence of m^5^CG in HCT116 cells ([Figure 10](#F10){ref-type="fig"}A), it is highly likely that G-m^5^CG in [Figure 10](#F10){ref-type="fig"}B was catalyzed by exogenously-added M.CviPI in addition to stand alone G-m^5^C (not in GCG sites). This same inference does not apply to RKO cell chromatin probed with M.CviPI in [Figure 10](#F10){ref-type="fig"}D. It can be inferred, however, that most G-m^5^CG is attributable to endogenous DNMTs due to high-density, stand alone m^5^CG in the control sample not probed with M.CviPI ([Figure 10](#F10){ref-type="fig"}C).

In HCT116 cells, two spans of consecutive sites were accessible to M.CviPI in each molecule ([Figure 10](#F10){ref-type="fig"}B). Seven of these eight regions were ∼150 bp in length and thus may correspond to nucleosome-free regions mapped by accessibility to M.SssI in transcriptionally-active LD419 cells ([@B72]). Each pair of M.CviPI-accessible regions flanks a ∼150 bp protected region, which is inferred to correspond to a single nucleosome of different translational position. Regions upstream and downstream of hyperaccessible regions associated with TSSa and TSSb of the h*MLH1* promoter in HCT116 cells, respectively, are likely to be protected by nucleosomes; however, their exact positions cannot be inferred in the absence of a defined linker region. Nonetheless, the majority of promoter sequences in these cells was inaccessible to M.CviPI and thus likely occupied by nucleosomes whose precise positions cannot be assigned.

Alignment and user-defined analysis of cytosine methylation of any specific site in bisulfite-converted sequences
-----------------------------------------------------------------------------------------------------------------

MethylViewer supports analysis of cytosine modification of any user-defined sequence. Analysis of C methylation in sequences containing degenerate bases is also supported by inputting IUPAC one-letter definitions, which are provided in a pop-up window upon selecting **Custom \> Custom methylation sites \> Show**. As many as four custom user-defined sites can be entered by selecting **Add**. The program is versatile enough to analyze C methylation in any sequence context by entering 'C' in **Create new site**. Four different symbols and six different colors are available for diagramming methylation of each bisulfite-converted sequence. As in the default CG and GC setting, if more than one site is selected; overlapping methylation is depicted as gray symbols. Custom site definitions can be saved by **Custom methylation sites \> File \> Save as** and reloaded by **Methylation sites \> File \> Open**.

To demonstrate MethylViewer's capability to analyze C modification at degenerate, non-palindromic sites, we integrated a single estrogen-inducible copy of the gene encoding M.CviPII into the budding yeast genome. This second DNMT from *Chlorella* virus NYs-1 was recently cloned and shown to methylate the first C in CCD sites, where D equals A, G, or T ([@B27]). The enzyme was reported to also methylate the first two cytosines in CCAA and CCCG sites. Genomic DNA was isolated from yeast cells incubated with 100 nM 17β-estradiol inducer or ethanol vehicle in rich medium. Following bisulfite conversion, a 500-bp region of the *PHO5* promoter, a locus with a well-characterized chromatin structure consisting of five upstream positioned nucleosomes (N−1 to N−5), was PCR amplified. Three and 17 independent clones from uninduced and estradiol-induced cells, respectively, were sequenced and analyzed by MethylViewer with custom sites of CCD, CCAA and CCCG designated ([Figure 11](#F11){ref-type="fig"}). Figure 11.MethylViewer analyses MAPit data using degenerate DNMT probe. (**A**) Publication-quality, scaled \*.svg image of bisulfite-converted *PHO5* sequences obtained from cells with uninduced (top panel) or estrogen-induced (bottom panel) expression of chromatin probe M.CviPII. Colors are as in other figures, except that CCD and m^5^CCD sites are indicated by filled white and filled purple triangles, respectively. (**B**) Edited grids used to export images in A. The settings for Base calling cutoff and Word size, were 200 and 15, respectively. (**C**) Overall methylation frequencies at each CCD site are indicated below the map showing placement of: positioned nucleosomes (ellipses labeled N−1, N−2 and N−3; Almer and Hörz, ([@B82]); upstream activating sequences at which Pho4 binds \[red-filled circles labeled UASp1 and UASp2 as mapped by Vogel and Hinnen ([@B83])\]; the compound Mcm1-Fkh site \[cyan-filled rectangle labeled UASm as described in Pondugula *et al.* ([@B81])\]; and TATA box (white-filled square); major TSS (bent arrow). According to the convention used in budding yeast, base pair coordinates are indicated relative to the first nucleotide of the ATG translational initiation start codon.

As expected, the final scaled \*.svg image of site accessibility to M.CviPII in the *PHO5* promoter amplicon shows no cytosines and hence no methylated sites among the three clones from cells where the M.CviPII transgene was uninduced ([Figure 11](#F11){ref-type="fig"}A and B, top panels). In contrast, 91 of 285 (32%) scored CCD sites were methylated in induced cells ([Figures 11](#F11){ref-type="fig"}A and B, bottom panels). Among 85 aligned CCAA sites, 25 were methylated, of which all were modified at the residue overlapping with the CCD specificity; i.e. the first, but not the second, C residue. No CCCG sites are present in the analyzed *PHO5* amplicon.

Summing the methylation percentage at each site over the 17 molecules methylated by M.CviPII shows that sequences in linkers between and at the edges of nucleosomes exhibited the highest frequencies of methylation ([Figure 11](#F11){ref-type="fig"}C), as we have previously shown ([@B37],[@B38]), with two exceptions. The first exception was a high level of m^5^CCD at site 16, which we have observed on occasion, and is possibly due to maximum curvature in nucleosomal DNA that occurs near this location ([@B74]). The second exception was relatively high accessibility to M.CviPII of various spans of sites (2:2 convention broken by separation of m^5^CCD sites by ≥30 bp), which are occupied by N−2 when transcription of the *PHO5* is repressed. Several accessible patches of varying length were also observed at the edge of N−3 and its adjacent linker DNA in a subset of molecules. We conclude that accessibility of chromatin can be probed by M.CviPII and rapidly analyzed and visualized by MethylViewer.

DISCUSSION
==========

MethylViewer is a versatile, user-friendly and intuitive graphical user interface program for processing BGS data. It can either directly process and align raw sequencing files or accept text files with pre-aligned sequences in FASTA format. An interactive grid of cells is returned that simplifies data editing and visually marks cells that have been edited and inspected for quality of sequencing calls, which are used to infer site methylation status. Viewed and edited cells in the methylation grid can be saved to files that can be opened at a future time and/or exported to images. With the exception of minor further editing to taste, the program also automatically generates publication-quality images of either the grid or standard 'lollipop' images that maintain widely accepted conventions for representing DNA methylation patterns. Users can also choose to include additional information in images, including the name of the sequence file to assist with data tracking, base pair coordinates of each queried methylation site, and dC bisulfite conversion efficiencies of cytosines not in queried methylation sites. The tab-delimited data in exported text files also make possible further external mathematical manipulations, such as correlation matrices and other statistical analyses.

MethylViewer provides a substantial advance over currently available BGS analysis programs, because it permits rapid and accurate interrogation of DNA methylation status of as many as four user-defined sites at a time in any biological system. The capability to specify analysis of multiple methylation sites is ideal for MAPit methylation footprinting that may employ more than one DNMT probe and/or detection of endogenous m^5^C ([Figures 7](#F7){ref-type="fig"} and 10). A crucial feature of MethylViewer for MAPit absent from other programs is the generation of scaled images with symbols spaced according to their relative position in the sequence. This allows more accurate placement of footprints. The graphical user interface of MethylViewer also constitutes a stand-alone, integrated solution for MAPit projects in that **Tools \> Bisulfite primer design ... **aids users in designing primers that meet the further challenge of avoiding probed GC sites in addition to endogenous CG sites. Analysis and primer design are also therefore not limited to sites commonly methylated in vertebrates (CG) and plants (CGN, CHG and CHH or CNG) as are other programs ([@B53],[@B54],[@B56; @B57; @B58; @B59; @B60]).

Furthermore, as MethylViewer is the only available program that can perform custom analysis of any and all cytosines in a sequence, computational analysis of BGS data is not limited to sites modified by DNMTs with known specificity. **Edit \> Create consensus ... **can be used determine the recognition site and methylated C for newly discovered or uncharacterized DNMTs, or the consensus site of a footprinted region in MAPit studies. In addition, the capability to query methylation status of C within any nearest-neighbor sequence context makes it possible for MethylViewer to support a myriad of additional BGS applications. For example, the program can be used to analyze BGS datasets from undifferentiated human embryonic stem cells that are reported to contain abundant non-CG methylation (m^5^CHG and m^5^CHH) ([@B19; @B20; @B21; @B22; @B23; @B24]). MethylViewer can also analyze BGS data from organisms, such as *Neurospora crassa* and *Ascobolus immersus*, which, respectively, pre-meiotically methylate DNA repeats at C-5 without strict site specificity ([@B18]). Lastly, MethylViewer can be used to analyze methylation by BGS that involves replicative incorporation of modified nucleotides, e.g. bacteriophage T4 or potential PCR applications.

We have shown that M.CviPI is as effective as M.SssI for probing chromatin structure of active loci at single-molecule resolution \[[Figures 7](#F7){ref-type="fig"}B and 10B; ([@B48],[@B49],[@B72])\]. In particular, similar accessibility of mostly nucleosome-length regions (∼147 bp) to both DNMT probes was found near h*MLH1* TSSa and TSSb in the colorectal cell lines HCT116 and LD419. However, unlike M.SssI, probing accessibility of GC sites with M.CviPI ([@B28]) enables simultaneous determination of both chromatin accessibility and endogenous m^5^CG in mammalian cells ([Figures 7](#F7){ref-type="fig"} and 10).

Availability of two other DNMTs with short recognition sites in addition to M.SssI, M.CviPI (GC) and M.CviPII (CCD, CCAA and CCCG), significantly increases the resolution for mapping chromatin structure. As seen in [Figure 11](#F11){ref-type="fig"}, 17-fold coverage of the *PHO5* promoter region probed with M.CviPII was able to detect overall preferential accessibility in linker regions between both N−1 and N−2 (sites 4, 6 and 7) and N−2 and N−3 (sites 12--14). Similar patterns of overall accessibility of the *PHO5* promoter and other loci to M.CviPII, M.CviPI and M.SssI have been observed. This demonstrates that single-molecule footprinting is reproducible with different DNMTs in diverse systems (cell types, loci and *in vitro*-assembled chromatin), and in different laboratories ([@B38],[@B40],[@B41],[@B75],[@B76]).

The single-molecule view afforded by MAPit allows one to obtain an accurate picture of how methylation is partitioned amongst the molecules. A good illustration of this occurred in the region occupied by *PHO5* N−2; sequenced promoter molecules clearly clustered into one subpopulation inaccessible to M.CviPII and another with stretches of accessible sequence. Different lengths of accessible sequence may represent partial or complete disassembly of N−2 nucleosomes or differential degrees of sliding of the N−2 octamer on individual molecules ([@B77]). Sites at the edges of positioned nucleosomes may also be accessed by DNMTs due to 'breathing' or site exposure at the entry-exit sites ([@B78; @B79; @B80]). The two distinct subpopulations may also be indicative promoters that have remodeled or are in the process of remodeling *PHO5* promoter chromatin. The experiment in [Figure 11](#F11){ref-type="fig"} was performed on a population of yeast cells grown asynchronously in rich medium, which contains cells that have activated *PHO5* transcription in M phase and have repressed transcription in G~1~ to early S phase ([@B81]). The MAPit results are thus consistent with subpopulations of yeast cells containing transcriptionally-active or -inactive copies of *PHO5*. Verification of this hypothesis and distinguishing between different possibilities of chromatin remodeling require more extensive MAPit analysis as well as additional studies.

In closing, MethylViewer should greatly facilitate efforts of genome-wide analysis of m^5^C via BGS. We will publicly host our server to the increasing number of researchers studying the role of DNA methylation in epigenetic regulation who we expect will find MethylViewer a valuable freely available resource.

SUPPLEMENTARY DATA
==================

[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkq716/DC1) are available at <http://dna.leeds.ac.uk/methylviewer/>.

###### Supplementary Data

FUNDING
=======

Cancer Research UK (to A.F.M.); Sir Jules Thorn Award for Biomedical Research (to D.T.B.); National Institutes of Health \[grant number CA095525 (to M.P.K.)\]; Department of Defense \[grant numbers BC062914 and BC087311 (to M.P.K.)\]; Bankhead-Coley Florida Cancer Research Program \[2009 Bridge Grant (to M.P.K.)\]. Funding for open access charge: Start-up funds from the University of Florida Shands Cancer Center, University of Florida College of Medicine.

*Conflict of interest statement*. The author M.P.K. has indicated that he shares royalties for the M.CviPI enzyme used as chromatin probe in the article with co-inventors.

The authors thank Christopher A. Fuhrman for construction of pCF1439 and yeast strains CFY4011 and CFY4012. The authors also thank Nancy H. Nabilsi for helpful suggestions of program features and for editing the manuscript.

[^1]: The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
